As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

It is the cost of the drugs that is at the center of the debate in Congress. (Sadly, it is not the needs of our seniors.) Advertising Will more money be spent, or saved, if weight loss drugs are ...

SEATTLE — High demand for weight loss drugs like Ozempic and Wegovy has led to the emergence of "knockoff" versions that may not be as safe as the FDA-approved, brand-name versions. The ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

Efforts to model the weight-loss drugs’ future impact are ... at the University of Washington in Seattle. Trials show that drugs such as semaglutide allow people to lose around 15% of their ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

“These drugs promote substantial weight loss, reducing obesity-related cancer ... researcher at the Fred Hutchinson Cancer Center in Seattle. Anne McTiernan, MD, PhD “There have been trials ...